Rigrodsky & Long, P.A. Investigates Buyout of Nationwide Health Properties, Inc. - NHP

  • Do you own Nationwide Health Properties, Inc. common stock?
  • Did you purchase your shares prior to February 28, 2011?
  • Do you feel the Company's sale to Ventas, Inc. is unfair?
  • Do you want to discuss your rights?

If the answer to these questions is "yes," please contact the deal lawyers at Rigrodsky & Long, P.A. ("R & L") today to schedule a FREE consultation. Just call us, or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.

Contact R & L today to be sure your best interests are being protected.

R & L is national law firm with decades of combined legal experience. R & L is investigating potential claims against the board of directors of Nationwide Health Properties, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Ventas, Inc. in a transaction with a  total value of approximately $7.4 billion.

Click here to read the full press release.

Rigrodsky & Long, P.A. Investigates Buyout of Nationwide Health Properties, Inc. - NHP

Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Nationwide Health Properties, Inc. (“Nationwide ” or the “Company”) (NYSE: NHP) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Ventas, Inc. (“Ventas”) (NYSE: VTR) in a transaction with a  total value of approximately $7.4 billion.

Under the proposed agreement, Nationwide shareholders will receive a fixed exchange ratio of 0.7866 Ventas shares for each share of Nationwide common stock they own.  Based on the closing stock price for Ventas on Friday, February 25, 2011, this consideration will be equivalent to $44.99 of Ventas stock for each Nationwide share.  Upon closing of the transaction, Ventas shareholders are expected to own approximately 65% and Nationwide shareholders are expected to own approximately 35% of the combined company.

The investigation concerns whether Nationwide’s board of directors failed to adequately shop the Company and obtain the best price possible for Nationwide’s shareholders before entering into the agreement with Ventas.  Indeed, according to Yahoo! Finance, at least one analyst has set a price target of $45.00 per share for Nationwide stock.

If you own the common stock of Nationwide and purchased your shares before February 28, 2011, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or by e-mail to info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

R & L, with offices in Delaware and New York, litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Learn more about R&L:  Visit Our Website |  Our Firm  |  Our Practice Areas  |  FAQ's

Fill out the form below or call us toll-free at 888-969-4242, for a FREE no-obligation consultation.